-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Initiates Coverage On ProKidney with Buy Rating, Announces Price Target of $12

Benzinga·12/16/2025 12:03:25
Listen to the news
HC Wainwright & Co. analyst Joseph Pantginis initiates coverage on ProKidney (NASDAQ:PROK) with a Buy rating and announces Price Target of $12.